Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold

Joanna Bojarska(Lodz University of Technology), Adam Mieczkowski(Institute of Biochemistry and Biophysics, Polish Academy of Sciences), Zyta M. Ziora(The University of Queensland), Mariusz Skwarczyński(The University of Queensland), István Tóth(The University of Queensland), Ahmed O. Shalash(The University of Queensland), Keykavous Parang(Target (United States)), Shaima A. El-Mowafi(Target (United States)), Eman H. M. Mohammed(Target (United States)), Sherif M. Elnagdy(Cairo University), Maha AlKhazindar(Cairo University), Wojciech M. Wolf(Lodz University of Technology)
Biomolecules
October 14, 2021
Cited by 111Open Access
Full Text

Abstract

Cyclic dipeptides, also know as diketopiperazines (DKP), the simplest cyclic forms of peptides widespread in nature, are unsurpassed in their structural and bio-functional diversity. DKPs, especially those containing proline, due to their unique features such as, inter alia, extra-rigid conformation, high resistance to enzyme degradation, increased cell permeability, and expandable ability to bind a diverse of targets with better affinity, have emerged in the last years as biologically pre-validated platforms for the drug discovery. Recent advances have revealed their enormous potential in the development of next-generation theranostics, smart delivery systems, and biomaterials. Here, we present an updated review on the biological and structural profile of these appealing biomolecules, with a particular emphasis on those with anticancer properties, since cancers are the main cause of death all over the world. Additionally, we provide a consideration on supramolecular structuring and synthons, based on the proline-based DKP privileged scaffold, for inspiration in the design of compound libraries in search of ideal ligands, innovative self-assembled nanomaterials, and bio-functional architectures.


Related Papers